Effect of extracorporeal membrane oxygenation transport on short- and long-term survival in patients with acute respiratory distress syndrome. Issue 1 (2nd January 2020)

• Record Type: Journal Article
• Authors: Steimer, Desiree A.; Hernandez, Omar; Ogola, Gerald; Mason, David P.; Schwartz, Gary S.
• Is Part Of: Proceedings. Volume 33:Issue 1(2020)
• Page Start: 5
• Page End: 9
• Publication Date: 2020-01-02
• Subjects: Acute respiratory distress syndrome -- ECMO outcomes -- ECMO transport -- extracorporeal membrane oxygenation; Medicine -- Periodicals; Medicine; Medicine -- Periodicals; Periodicals; Electronic journals; 616.005
• DOI: 10.1080/08998280.2019.1669120
• Languages: English
• ISSNs: 0899-8280

Abstract

Abstract: Venovenous extracorporeal membrane oxygenation (ECMO) has emerged as an important tool in the treatment of acute respiratory distress syndrome (ARDS). The creation of portable ECMO circuits and pumps has supported the development of interfacility ECMO programs. Prior studies have demonstrated that ECMO transport is safe; however, long-term outcomes for these patients remain unknown. Retrospective analysis of our 5-year experience identified 58 patients transported on ECMO and 82 patients cannulated at our institution. When short-term (30 days) and long-term (1 year) outcomes were compared between these cohorts, there was no statistically significant difference in survival ( P = 0.44 and 0.49). There were no deaths related to transport, and the rate of ECMO-related complications was similar between the groups. With established patient safety and similar long-term survival, ECMO transport is a feasible solution to provide access to ECMO for all communities.